[Federal Register Volume 70, Number 40 (Wednesday, March 2, 2005)]
[Notices]
[Page 10076]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-4029]



[[Page 10076]]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the Uniform Formulary 
Beneficiary Advisory Panel. The panel will review and comment on 
recommendations made to the Director, TRICARE Management Activity, by 
the Pharmacy and Therapeutics Committee regarding the Uniform 
Formulary. The meeting will be open to the public. Seating is limited 
and will be provided only to the first 220 people signing in. All 
persons must sign in legibly. Notice of this meeting is required under 
the Federal Advisory Committee Act.

DATES: Wednesday, March 23, 2005, from 8 a.m. to 4 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Rich Martel, TRICARE Management 
Activity, Pharmacy Operations, Beneficiary Advisory Panel, Suite 810, 
5111 Leesburg Pike, Falls Church, VA 22041, telephone 703-681-0064 ext. 
3672, fax 703-681-1242, or e-mail at [email protected].

SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory 
Panel will only review and comment on the development of the uniform 
formulary as reflected in the recommendations of the Pharmacy and 
Therapeutics (P&T) Committee coming out of that body's meeting in 
February 2005. The DoD P&T information and subject matter for that 
meeting are available at http://pec.ha.osd.mil. Any private citizen is 
permitted to file a written statement with the advisory panel. 
Statements must be submitted electronically to The Uniform Formulary 
Beneficiary Advisory Panel, c/o Mr. Richard Martel, 
[email protected]. In order to be considered by the panel 
prior to the meeting, statements must be submitted electronically no 
later than March 16, 2005. Any private citizen is permitted to speak at 
the Beneficiary Advisory Panel meeting, time permitting. One hour has 
been reserved for public comments, and speaking times will be assigned 
on a first-come, first-served basis. The amount of time allocated to a 
speaker will not exceed five minutes. Private citizens wishing to speak 
at the meeting may sign up at the meeting on a first-come, first-served 
basis.

    Dated: February 25, 2005.
Jeannette Owings-Ballard,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 05-4029 Filed 3-1-05; 8:45 am]
BILLING CODE 5001-06-M